A specific β3-adrenoceptor agonist induces increased pancreatic islet blood flow and insulin secretion in rats

European Journal of Pharmacology

Volumn 298, Issue 3, 1996, Pages 287-292

  Atef, Nadia ^a   Lafontan, Max ^b   Doublé, Alexandre ^a   Hélary, Christophe ^a   Ktorza, Alain ^a   Pénicaud, Luc ^a  

^a CNRS   (France)

^b INSERM   (France)

Author keywords

Blood flow; Blood pressure; Glucose; Insulin; Pancretic islet; adrenoceptor

Indexed keywords

5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA3 ADRENERGIC ANTAGONIST; BUPRANOLOL; GLUCOSE; INSULIN; NADOLOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DRUG ANTAGONISM; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MICROVASCULATURE; NONHUMAN; PANCREAS BLOOD FLOW; PANCREAS ISLET; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0029670132     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00802-0     Document Type: Article

References (35)

1. Atef, N., A. Ktorza, L. Picon and L. Pénicaud, 1992, Increased islet blood flow in obese rats: role of the autonomie nervous system, Am. J. Physiol. 262, E736.
2. Atef, N., B. Portha and L. Pénicaud, 1994 Changes in islet blood flow in rats with NIDDM, Diabetologia 37, 677.
3. Berlan, M., J. Galitzky, A. Bousquet-Melou, M. Lafontan and J.L. Montastruc 1994, Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog, J. Pharmacol. Exp. Ther. 268, 1444.
4. Bloom, J.D., M.D. Dutia, B.D. Johnson, A. Wissner, M.G. Bums, E.E. Largis, J.A. Dolan and T.H. Claus, 1992 Disodium (R,R)-5-[2[[2(3 chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316243). A potent beta-adrenergic agonist virtually specific for beta3 receptors. A promising antidiabetic and antiobesity agent, J. Med. Chem. 35, 3081.
5. Caroll, M.J., C.A. Lister, M.V. Sennitt, V. Stewart-Long and M.A. Cawthorne, 1985, Improved glyacemic control in C57B1/KsJ(db/db) mice after treatment with the thermogenic β-adrenoceptor agonist BRL 26830A, Diabetes 24, 1198.
6. Cawthorne, M.A., M.J. Caroll and A.L. Levy, 1984, Effect of novel β-adrenoceptor agonists on carbohydrate metabolism: relevance for the treatment of non-insulin-dependent diabetes, Int. J. Obes. 8 (Suppl. 1), 93.
7. Dolan, J.A., H.A. Muenkel, M.G. Burns, S.M. Pellegrino, C.M. Fraser, F. Pietri, A.D. Strosberg, E.E. Largis, M.D. Dutia, J.D. Bloom, A.S. Bass, T.K. Tanikella, A.G. Cobuzzi, P.M. Lai and T.H. Claus, 1994, Beta-3-adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines, J. Pharmacol. Exp. Ther. 269, 1000.
8. Ferré, P., L. Pénicaud, Y. Hitier, Meier, M. and J. Girard, 1992, Hypoglycemic effects of a β-agonist, RO 16-8714, in streptozotocin-diabetic rats: decreased hepatic glucose production and increased glucose utilization in oxidative muscles, Metabolism 41, 180.
9. Ford, A.P.D.W., D.T. Taneja and D.E. Clarke, 1992, Atipycal β-adrenoceptor-mediated relaxation and cyclic-AMP formation in tunica muscularis mucosae (TMM) of the rat oesophagus, Br. J. Pharmacol. 105 (Suppl.), 235P.
10. Galitzky, J., M. Reverte, C. Carpene, M. Lafontan and M. Berlan, 1993a, β3-Adrenoceptors in dog adipose tissue: studies on their involvment in the lipomobilizing effect of catecholamines, J. Pharmacol. Exp. Ther. 266, 358.
11. Galitzky, J., M. Reverte, M. Portillo, C. Carpene, M. Lafontan and M. Berlan, 1993b, Coexistence of β1, β2 and β3-adrenoceptors in dog fat cells and their differential activation by catecholamines, Am. J. Physiol. 264, E403.
12. Granneman, J.G., K.N. Lahners and A. Chaudhry, 1991, Molecular cloning and expression of the rat β3-adrenergic receptor, Mol. Pharmacol. 40, 895.
13. Himms-Hagen, J., J. Cui, E. Danforth, D.J. Taatjes, S.S. Lang, B.L. Waters and T.H. Claus, 1994, Effect of CL 316243, a thermogenic beta3-agonist, on energy balance and brown and white adipose tissues in rats, Am. J. Physiol. 35, R1371.
14. Jansson, L., 1984, The blood flow to the pancreas and islet of Langerhans during an intraperitoneal glucose load in the rat. Diabetes Res. Clin. Pratice 1, 111.
15. Jansson, L. and C. Berne, 1993, Hypoglycemia and pancreatic islet blood flow in the rat: evidence for a decreased islet blood perfusion mediated by the central nervous system, Acta Endocrinol. 128 (Suppl. 1), 10.
16. Jansson, L. and C. Hellerström, 1981, A rapid method of visualizing the pancreatic islets of studies of islet capillary blood flow using non radioactive microspheres, Acta Physiol. Scand. 113, 371.
17. Jansson, L. and C. Hellerström, 1983, Stimulation by glucose of the blood flow to the pancreatic islets of the rats, Diabetologia 25, 45.
18. Jansson, L. and C. Hellerström, 1986, Glucose induced changes in pancreatic islet blood flow mediated by central nervous system, Am. J. Physiol. 251, E644.
19. Jansson, L., D.L. Eizirik and S. Sandler, 1989, Terbutaline decreases the blood flow of the pancreatic islets but does not reduce the diabetogenic action of streptozotocin in the rat, Eur. J. Pharmacol. 161, 79.
20. Krief, S., F. Lönnqvist, S. Raimbault, B. Baude, A. Van Spronsen, P. Amer, A.D. Strosberg, D. Ricquier and L.J. Emorine, 1993, Tissue distribution of β3-adrenergic receptor mRNA in man, J. Clin. Invest. 91, 344.
21. Lacey, R.J., N.S. Berrow, J.H. Scarpello and N.G. Morgan, 1991, Selective stimulation of glucagon secretion by beta-2-adrenoceptors in isolated islets of Langerhans of the rat, Br. J. Pharmacol. 103, 1824.
22. Langin, D., M.P. Portillo, J.S. Saulnier-Blache and M. Lafontan, 1991, Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species, Eur. J. Pharmacol. 199, 291.
23. McGrath, J.C., C.M. Brown and V.G. Wison, 1989, Alpha-adrenoceptors: a critical review, Med. Res. Rev. 9, 408.
24. Meyer, H.H., F. Vetterlein, G. Schmidt and A. Hasselblatt, 1982, Measurement of blood flow in pancreatic islets of the rat: effect of isoproterenol and norepinephrine, Am. J. Physiol. 242, E298.
25. Rappaport, A.M., T. Kawamura, J.K. Davidson, B.J. Lin, S. Ohira, M. Zeigler, J.A. Goddling, J. Henderson and R.E. Haist, 1971, Effects of hormones and of blood flow on insulin output of isolated pancreas in situ, Am. J. Physiol. 221, 343.
26. Rooth, P. and I.B. Täljedal, 1987, Vital microscopy of islet blood flow: Catecholamine effects in normal an ob/ob mice, Am. J. Physiol. 252, E130.
27. Rooth, P., K. Grankvist and I.B. Täljedal, 1985, In vivo fluorescence microscopy of blood flow in mouse pancreatic islets: adrenergic effect in lean an obese hyperglycemic mice, Microvasc. Res. 30, 176.
28. Sennitt, M.V., J.R.S. Arch, A.L. Levy, D.L. Simson, S.A. Smith and M.A. Cawthorne, 1985, Anti-hyperglycaemic action of BRL 26830, a novel β-adrenoceptor agonist, in mice and rats, Biochem. Pharmacol. 34, 1279.
29. Shen, Y.T., H. Zhang and S.F. Vatner 1994, Peripheral vascular effects of beta-3 adrenergic receptor stimulation in conscious dogs, J. Pharmacol. Exp. Ther. 268, 466.
30. Smith, S.A., A.L. Levy, M.V. Sennitt, D.L. Simson and M.A. Cawthome, 1985, Effect of BRL 26830, a novel β-adrenoceptor agonist, on glucose tolerance, insulin sensitivity and glucose turnover in Zucker (fa/a) rats, Biochem. Pharmacol. 34, 2425.
31. Sparrow, R.A. and I.J. Beckingham, 1989, Islet blood flow following insulin administration, J. Anat. 163, 75.
32. Takahashi, H., T. Yoshida, M. Nishimura, T. Nakanishi, M. Kondo and M. Yoshimura, 1992, Beta-3 adrenergic agonist, BRL 26830A, and alpha/beta blocker, arotinolol, markedly increase regional blood flow in brown adipose tissue in anesthetized rats, Jpn. Circ. J. 56, 936.
33. Taneja, D.T. and D.E. Clarke, 1992, Evidence for a noradrenergic innervation to atypical beta adrenoceptors (or putative beta 3 adrenoceptors) in the illeum of guinea pig, J. Pharmacol. Ther. 260, 192.
34. Vetterlein, F., D. Senske, C. Bornkessel and G. Scmidt, 1985, Effect of tolbutamide on blood flow in islets and exocrine tissue of the rat pancreas, Eur. J. Pharmacol. 113, 395.
35. Yoshida, T., 1992, The antidiabetic β3-adrenoceptor agonist BRL 26830 works by release of endogenous insulin, Am. J. Clin. Nutr. 55, 237S.